Enterprise Value
102.8M
Cash
25.11M
Avg Qtr Burn
-11.63M
Short % of Float
0.08%
Insider Ownership
70.08%
Institutional Own.
3.64%
Qtr Updated
03/31/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
AP-PA02 Details Non-Cystic Fibrosis Bronchiectasis | Phase 2 Data readout | |
AP-SA02 Details Bacterial infection | Phase 1/2 Interim update | |
AP-PA02 Details Cystic fibrosis | Phase 1/2 Update |